IMRX
Immuneering·NASDAQ
--
--(--)
--
--(--)
IMRX fundamentals
Immuneering (IMRX) released its earnings on Nov 12, 2025: revenue was 0 (YoY 0.00%), beat estimates; EPS was -0.38 (YoY +22.45%), beat estimates.
Revenue / YoY
0
0.00%
EPS / YoY
-0.38
+22.45%
Report date
Nov 12, 2025
IMRX Earnings Call Summary for Q3,2025
- Breakthrough Pancreatic Cancer Data: 86% overall survival at nine months vs. 47% standard care, with complete responses in FOLFIRINOX combo arm.
- $227M Cash Runway: 2029 funding secured for phase 3 trial and lung cancer collaborations.
- Unique Mechanism: Deep cyclic MEK inhibition blocks resistance, no MAPK pathway mutations detected.
- Upcoming Trials: Phase 3 pancreatic cancer start mid-2026; Libtayo lung trial H2 2026; Lilly KRAS G12C combo pending.
EPS
Revenue
Revenue & Expenses
Key Indicators
Immuneering (IMRX) key financial stats and ratios, covering profitability, financial health, and leverage.
Immuneering (IMRX)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Immuneering (IMRX)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Immuneering (IMRX)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Immuneering (IMRX) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Immuneering (IMRX) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What is Immuneering's gross profit margin?What were the key takeaways from Immuneering's earnings call?What guidance did Immuneering's management provide for the next earnings period?What is Immuneering's latest dividend and current dividend yield?Did Immuneering beat or miss consensus estimates last quarter?What factors drove the changes in Immuneering's revenue and profit?What is the market's earnings forecast for Immuneering next quarter?What is the revenue and EPS growth rate for Immuneering year over year?
